Emil Aagaard Thomsen

In Vivo Knockout of the Vegfa Gene by Lentiviral Delivery of CRISPR/Cas9 in Mouse Retinal Pigment Epithelium Cells

Andreas Holmgaard, Anne Louise Askou, Josephine Natalia Esther Benckendorff et al. · Molecular Therapy — Nucleic Acids · 2017 · 73 citations · Full text

Engineered lentivirus-derived nanoparticles (LVNPs) for delivery of CRISPR/Cas ribonucleoprotein complexes supporting base editing, prime editing and <i>in vivo</i> gene modification

Jakob Haldrup, Sofie Andersen, Alexander Rafael LaVilla Labial et al. · Nucleic Acids Research · 2023 · 52 citations · Full text

Engineering, In Vivo Gene Therapy, Molecular Biology +20

pegIT - a web-based design tool for prime editing

Mads Valdemar Anderson, Jakob Haldrup, Emil Aagaard Thomsen et al. · Nucleic Acids Research · 2021 · 50 citations · Full text

Engineering, Visual Programming Language, Genetics +20

A genome-wide CRISPR-Cas9 knockout screen identifies novel PARP inhibitor resistance genes in prostate cancer

Malene Blond Ipsen, Ea Marie Givskov Sørensen, Emil Aagaard Thomsen et al. · Oncogene · 2022 · 31 citations

Molecular Biology, Gene Editing, Genome Editing +5

MicroRNA-155 controls vincristine sensitivity and predicts superior clinical outcome in diffuse large B-cell lymphoma

Hanne Due, Anna A. Schönherz, Laura Barrett Ryø et al. · Blood Advances · 2019 · 30 citations · Full text

Immunology, Pathology, Immunotherapy +16